MCR-1-dependent lipid remodelling compromises the viability of Gram-negative bacteria
收藏DataCite Commons2024-02-14 更新2024-07-29 收录
下载链接:
https://tandf.figshare.com/articles/dataset/MCR-1-dependent_lipid_remodeling_compromises_the_viability_of_Gram-negative_bacteria/19613914/2
下载链接
链接失效反馈官方服务:
资源简介:
The global dissemination of the mobilized colistin resistance gene, <i>mcr-1</i>, threatens human health. Recent studies by our group and others have shown that the withdrawal of colistin as a feed additive dramatically reduced the prevalence of <i>mcr-1</i>. Although it is accepted that the rapid reduction in <i>mcr-1</i> prevalence may have resulted, to some extent, from the toxic effects of MCR-1, the detailed mechanism remains unclear. Here, we found that MCR-1 damaged the outer membrane (OM) permeability in <i>Escherichia coli</i> and <i>Klebsiella pneumonia</i> and that this event was associated with MCR-1-mediated cell shrinkage and death during the stationary phase. Notably, the capacity of MCR-1-expressing cells for recovery from the stationary phase under improved conditions was reduced in a time-dependent manner. We also showed that mutations in the potential lipid-A-binding pocket of MCR-1, but not in the catalytic domain, restored OM permeability and cell viability. During the stationary phase, PbgA, a sensor of periplasmic lipid-A and LpxC production that performed the first step in lipid-A synthesis, was reduced after MCR-1 expression, suggesting that MCR-1 disrupted lipid homeostasis. Consistent with this, the overexpression of LpxC completely reversed the MCR-1-induced OM permeability defect. We propose that MCR-1 causes lipid remodelling that results in an OM permeability defect, thus compromising the viability of Gram-negative bacteria. These findings extended our understanding of the effect of MCR-1 on bacterial physiology and provided a potential strategy for eliminating drug-resistant bacteria.
可移动黏菌素耐药基因<em>mcr-1</em>(mobilized colistin resistance gene, mcr-1)的全球传播对人类健康构成威胁。本团队及其他学者的近期研究表明,停用黏菌素作为饲料添加剂后,<em>mcr-1</em>的流行率显著下降。尽管学界普遍认为,<em>mcr-1</em>流行率的快速下降在一定程度上可能与MCR-1的毒性效应有关,但其具体分子机制仍不明确。本研究发现,MCR-1会损伤大肠埃希菌(<i>Escherichia coli</i>)与肺炎克雷伯菌(<i>Klebsiella pneumoniae</i>)的外膜(outer membrane, OM)通透性,且该现象与静止期内MCR-1介导的细胞皱缩及死亡相关。值得注意的是,在优化培养条件下,表达MCR-1的细菌从静止期恢复的能力随时间推移逐渐降低。本研究还证实,MCR-1的潜在脂质A(lipid-A)结合口袋发生突变后,可恢复外膜通透性与细胞活力,但催化结构域(catalytic domain)的突变则无此效果。在静止期内,表达MCR-1后,作为周质脂质A传感器及参与脂质A合成第一步的LpxC产生调控因子的PbgA的表达量下调,提示MCR-1会扰乱脂质稳态。与此一致的是,过表达LpxC可完全逆转MCR-1诱导的外膜通透性缺陷。本研究提出,MCR-1可引发脂质重塑,进而导致外膜通透性缺陷,最终削弱革兰氏阴性菌(Gram-negative bacteria)的生存活力。本研究结果加深了我们对MCR-1调控细菌生理活动机制的理解,并为清除耐药菌提供了潜在策略。
提供机构:
Taylor & Francis
创建时间:
2022-04-28



